Latest Breaking News On - Timothy eugene sullivan - Page 4 : vimarsana.com

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) CFO Sells $234,640 00 in Stock

Apellis Pharmaceuticals, Inc (NASDAQ:APLS) CFO Sells $234,640 00 in Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesTimothy eugene sullivanQuarter for apellis pharmaceuticalsAmerican century companies incApellis pharmaceuticals incMetlife investment managementUs bancorpGoldman sachs groupHedge funds weigh in on apellis pharmaceuticalsYork mellon corpNews ratings for apellis pharmaceuticals dailySecurities exchange commissionWells fargo companyApellis pharmaceuticals stock performanceApellis pharmaceuticalsGet free report

Insider Selling: Apellis Pharmaceuticals, Inc (NASDAQ:APLS) CFO Sells 4,000 Shares of Stock

Insider Selling: Apellis Pharmaceuticals, Inc (NASDAQ:APLS) CFO Sells 4,000 Shares of Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond jamesTimothy eugene sullivanUs bancorpStephens consultingJpmorgan chase coApellis pharmaceuticals incQuarter for apellis pharmaceuticalsFirst horizon advisors incCovestor ltdInstitutional trading of apellis pharmaceuticalsApellis pharmaceuticalsApellis pharmaceuticals company profileApellis pharmaceuticals price performanceGoldman sachs groupNews ratings for apellis pharmaceuticals daily

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Reaffirmed by Mizuho

Apellis Pharmaceuticals (NASDAQ:APLS) Stock Rating Reaffirmed by Mizuho
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMark jeffrey delongRaymond jamesTimothy eugene sullivanWells fargo companyNews ratings for apellis pharmaceuticals dailyUs bancorpAnalyst recommendations for apellis pharmaceuticalsApellis pharmaceuticals trading downStephens consultingApellis pharmaceuticals company profileGoldman sachs groupFirst horizon advisors incCovestor ltdInsider transactions at apellis pharmaceuticalsInstitutional trading of apellis pharmaceuticals

Oppenheimer Raises Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $79 00

Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price boosted by stock analysts at Oppenheimer from $75.00 to $79.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price objective suggests a potential upside of 20.78% from the […]

Pascal deschateletsTimothy eugene sullivanJpmorgan chase coApellis pharmaceuticalsWells fargo companyApellis pharmaceuticals incJennison associatesMorgan stanleyNorges bankInstitutional trading of apellis pharmaceuticalsSecurities exchange commissionPricet rowe associates incApellis pharmaceuticals stock performanceAnalyst recommendations for apellis pharmaceuticalsNews ratings for apellis pharmaceuticals dailyNeedham company

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $75 00

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Raised to $75 00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesJames george chopasTimothy eugene sullivanCapital investment advisorsChina universal asset management coApellis pharmaceuticalsApellis pharmaceuticals stock downGoldman sachs groupApellis pharmaceuticals incHc advisorsSecurities exchange commissionHedge funds weigh in on apellis pharmaceuticalsAltfest lj coAnalyst recommendations for apellis pharmaceuticalsNews ratings for apellis pharmaceuticals dailyNeedham company